Yasser Shahzad

Yasser Shahzad


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
YSYasser Shahzad
Yasser Shahzad
RLRuaan Louw
Ruaan Louw
Minja GerberMinja Gerber
Minja Gerber
JPJeanetta Du Plessis
Jeanetta Du Plessis

1 March 2014 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
KSKashif Sohail
Kashif Sohail
IKIkram Ullah Khan
Ikram Ullah Khan
YSYasser Shahzad
Yasser Shahzad
THTalib Hussain
Talib Hussain
NRNazar Muhammad Ranjha
Nazar Muhammad Ranjha
In this study, we fabricated pH-sensitive polyvinylpyrrolidone/acrylic acid (PVP/AA) hydrogels by a free-radical polymerisation method with variation in the content of monomer, polymer and cross-linking agent. Swelling was performed in USP phosphate buffer solutions of pH 1.2, 5.5, 6.5 and 7.5 with constant ionic strength. Network structure was evaluated by different parameters and FTIR confirmed the formation of cross-linked hydrogels. X-ray crystallography showed molecular dispersion of tramadol HCl. A drug release study was carried out in phosphate buffer solutions of pH 1.2, 5.5 and 7.5 for selected samples. It was observed that swelling and drug release from hydrogels can be modified by changing composition and degree of cross-linking of the hydrogels under investigation. Swelling coefficient was high at higher pH values except for the one containing high PVP content. Drug release increased by increasing the pH of the medium and AA contents in hydrogels while increasing the concentration of cross-linking agent had the opposite effect. Analysis of the drug release mechanism revealed non-Fickian transport of tramadol from the hydrogels.

1 February 2019 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
AYAbid Yousaf
Abid Yousaf
Usman Rashid MalikUsman Rashid Malik
Usman Rashid Malik
YSYasser Shahzad
Yasser Shahzad
TMTariq Mahmood
Tariq Mahmood
THTalib Hussain
Talib Hussain
The aim of this work was to develop, optimize and characterize a silymarin-laden polyvinylpyrrolidone (PVP)-polyethylene glycol (PEG) polymeric composite to resolve low aqueous solubility and dissolution rate problem of the drug. A number of silymarin-laden polymeric formulations were fabricated with different quantities of PVP K-30 and PEG 6000 by the solvent-evaporation method. The effect of PVP K-30 and PEG 6000 on the aqueous solubility and dissolution rate was investigated. The optimized formulation and its constituents were characterized using powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) techniques. Both the PEG 6000 and PVP K-30 positively affected the aqueous solubility and dissolution rate of the drug. In particular, a formulation consisting of silymarin, PVP K-30 and PEG 6000 (0.25/1.5/1.5, w/w/w) furnished the highest solubility (24.39±2.95 mg/mL) and an excellent dissolution profile (~100% in 40 min). The solubility enhancement with this formulation was ~1150-fold as compared to plain silymarin powder. Moreover, all the constituents existed in the amorphous state in this silymarin-laden PVP-PEG polymeric composite. Accordingly, this formulation might be a promising tool to administer silymarin with an enhanced effect via the oral route.

1 August 2020 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
YHYeteng He
Yeteng He
KMKhadija Majid
Khadija Majid
MMMaimoona Maqbool
Maimoona Maqbool
THTalib Hussain
Talib Hussain
AYAbid Mehmood Yousaf
Abid Mehmood Yousaf
YSYasser Shahzad
Yasser Shahzad
Rheumatoid arthritis (RA) is an autoimmune disease associated with severe joint pain. Herein, we report lornoxicam loaded cellulosic microsponge gel formulation with sustained anti-inflammatory effects that are required to manage arthritic pain. The microsponges were formulated using quasi emulsion-solvent diffusion method employing four different surfactant systems, namely polyvinyl alcohol (PVA), Tween80, Gelucire 48/16 and Gelucire 50/13. All the lornoxicam loaded microsponge formulations were extensively characterized with a variety of analytical tools. The optimized microsponge formulation was then converted into gel formulation. The lornoxicam loaded microsponge gel formulation had adequate viscosity and sufficient pharmaceutical properties as confirmed by the texture analysis and the drug release followed Super case II transport. It is noteworthy that we described the preparation of a new cellulosic polymers based microsponge system for delivery of lornoxicam to provide quick as well as lasting (sustained) anti-inflammatory effects in rats using carrageenan induced rat paw edema model. We were able to demonstrate a 72% reduction in inflammation within 4 h using the optimize transdermal gel formulation utilizing Transcutol P as permeation enhancer and with the aid of skin micro-piercing by microneedles, hence, demonstrating the potential of this microsponge gel formulation in arthritis management.

1 January 2011 in Designed Monomers and Polymers
Verified
Journal Article
Closed access
THTalib Hussain
Talib Hussain
NRNazar Muhammad Ranjha
Nazar Muhammad Ranjha
YSYasser Shahzad
Yasser Shahzad
In the present study pH-sensitive polyvinylpyrrolidone/acrylic acid (PVP/AA) hydrogels were synthesized by free radical polymerization in the presence of ethylene glycol dimethacrylate (EGDMA) as a...

1 April 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YSYasser Shahzad
Yasser Shahzad
SSSidra Saeed
Sidra Saeed
MGMuhammad Usman Ghori
Muhammad Usman Ghori
TMTariq Mahmood
Tariq Mahmood
AYAbid Mehmood Yousaf
Abid Mehmood Yousaf
SRSyed A.A. Rizvi
Syed A.A. Rizvi